Enanta Pharmaceuticals (ENTA) PT Lowered to $44 at SVB Leerink
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Price: $13.32 +0.68%
Rating Summary:
11 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
11 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
SVB Leerink analyst Roanna Ruiz lowered the price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $44.00 (from $58.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- QuantumScape (QS) PT Lowered to $6 at Truist Securities
- Thyssenkrupp AG (TKA:GR) (TYEKF) PT Lowered to EUR5 at Barclays
- American International Group (AIG) PT Raised to $89 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
